Multimedia Release

Scaling up a Nanoimmunotherapy for Atherosclerosis Through Preclinical Testing (1 of 8)

Reports and Proceedings

American Association for the Advancement of Science (AAAS)

Scaling up a Nanoimmunotherapy for Atherosclerosis Through Preclinical Testing (1 of 8)

image: The new imaging technique was used to guide nanoimmunotherapy (S-HDL) and study blood vessel inflammation in rabbits (top) and pigs (bottom). This material relates to a paper that appeared in the Aug. 21, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by T. Binderup at Icahn School of Medicine at Mount Sinai in New York, NY; and colleagues was titled, "Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species." view more 

Credit: [Credit: T. Binderup <i>et al., Science Translational Medicine</i> (2019)]


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.